WOBURN, Mass., Feb. 23, 2017 /Weed Wire/ — Courtagen Life Sciences, Inc., an innovative endocannabinoid platform and molecular information company, announced today that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no. 14/895,557, titled “Methods and Kits for Treating and Classifying Individuals at Risk of or Suffering from TRAP1 Change-of-Function.”
Tag Archives: Mike Catalano
WOBURN, Mass., Feb. 10, 2017 /Weed Wire/ — Medicinal Genomics and Courtagen Life Sciences, today announced an increasingly influential speaker lineup for CannMed 2017.
WOBURN, Mass., Jan. 25, 2017 /Weed Wire/ — Medicinal Genomics (MGC) and Courtagen Life Sciences today announced that the National Institute on Drug Abuse (NIDA) has awarded the company an SBIR Phase I grant to develop a novel test to detect toxins resulting from microbiological contamination of medical cannabis.
WOBURN, Mass., Jan. 12, 2017 /Weed Wire/ — Courtagen Life Sciences and Medicinal Genomics today announced a partnership with TheAnswerPage.com to provide continuing medical education (CME) credits to physicians and other healthcare professionals for the upcoming CannMed 2017 Personalized Cannabinoid Medicine Conference